Top Markets
#1 EXOD EXOD +56.80%
#2 Glidr Glidr +35.94%
#3 Cysic Cysic +23.33%
#4 Solv Protocol xSolvBTC Solv Protocol xSolvBTC +22.84%
#5 Victoria VR Victoria VR +21.15%
#6 Nockchain Nockchain +18.95%
#7 Bedrock Bedrock +17.00%
#8 Versatize Coin Versatize Coin +12.50%
#9 Perle Perle +12.25%
#10 Velvet Velvet +12.00%
Coin of the day
EXOD EXOD
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Peak Bio, Inc. Peak Bio, Inc.

Peak Bio, Inc.

PKBO
Rangering i aksjer #37553
Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical... Peak Bio, Inc. is a biopharmaceutical firm currently in the clinical development phase, committed to devising treatments for critical, unmet medical needs in the realms of oncology and inflammatory disorders. The company harnesses its unique, proprietary toxin—known as PH-1 or Thailanstatin—a spliceosome modulator, to create its inaugural range of innovative Antibody-Drug Conjugate (ADC) therapies designed for cancer patients facing significant challenges. Additionally, Peak Bio's leading investigational drug, PHP-303, a small molecule, is on the verge of commencing a Phase II dose clinical trial for the rare condition Alpha1 anti-trypsin deficiency (AATD). The company's operations are situated in Palo Alto, California.
Aksjekurs
$0.07
Sist synkronisert: 2024-11-12
Markedsverdi
$1.62M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Peak Bio, Inc. (PKBO)

Kategori

Healthcare
Aksjeprishistorikk for Peak Bio, Inc. (PKBO)
Høyeste sluttskurs: $0.07 den 2024-11-01

Laveste sluttskurs: $9.71 den 2021-03-01
Aksjeprishistorikk for Peak Bio, Inc. fra 2021 til 2026
Årlig aksjeprisytelse
År Ytelse
2024 -26.66%
2023 -98.23%
2022 -44.81%
2021 0.00%
Aksjepris for lignende selskaper eller konkurrenter
Selskap Aksjepris Endring 1år% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $505.24 28.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $846.09 29.41%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $731.69 6.47%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.07K -6.40%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $251.82 11.75%
BE